May 07, 2020
Duchenne Muscular Dystrophy Market is Anticipated to Grow With a CAGR of 31.8% for the Study Period of 2017-2030: DelveInsight
Apr 14, 2020
Granata Bio and IBSA Group Announce Strategic Partnership
Mar 18, 2020
Pharmascience Inc. launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the maintenance treatment of asthma and COPD
Mar 06, 2020
FDA Approves New Treatment for Adults with Cushing's Disease
Mar 02, 2020
Eyevance Pharmaceuticals launches TOBRADEX® ST in the United States
Mar 02, 2020
Eyevance Pharmaceuticals launches TOBRADEX® ST in the United States
Oct 23, 2019
Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Oct 15, 2019
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
Oct 03, 2019
ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study
Aug 20, 2019
Forendo Pharma Commences Phase 1b Proof of Mechanism Study with its Lead Endometriosis Program, HSD17B1 Inhibitor FOR-6219
Jun 07, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age
Apr 30, 2019
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
Mar 05, 2019
Enteris BioPharma Supports Endometriosis Awareness Month
Feb 13, 2019
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
Feb 12, 2019
Mylan Launches Wixela(TM) Inhub(TM) (fluticasone propionate and salmeterol inhalation powder, USP), the First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder), at a List Price 70% Less than the Brand
Jan 17, 2019
Parent Project Muscular Dystrophy Publishes 10 Year Registry Report
Jan 08, 2019
Calliditas Therapeutics Appoints Andrew Udell to VP Commercial, North America
Jan 02, 2019
Slayback Pharma announces FDA approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial
Oct 26, 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Oct 17, 2018
New Shady Grove Fertility Study Reveals that Fewer Injections During a Frozen Embryo Transfer (FET) Cycle Resulted in Equivalent Live Birth Rates